Fluctuations in serum amylase in patients with macroamylasemia. 1995

C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
Long Island Jewish Medical Center, Albert Einstein College of Medicine, Division of Gastroenterology, New Hyde Park, New York, USA.

OBJECTIVE To report wide fluctuation of serum amylase in patients with macroamylasemia. It has generally been considered to remain constant. METHODS Over the past 16 y, 18 patients have been diagnosed with macroamylasemia in our GI department. Of these, four patients were followed up with serial serum amylase determinations for a period of less than 1-4 y. Serum amylase was measured by the "Phadebas amylase test." Serum macroamylase was measured by "PEG precipitation technique." RESULTS There was a wide fluctuation of serum amylase in three out of four patients. In the fourth patient, more persistent hyperamylasemia was noted during the shorter observation period. CONCLUSIONS Marked fluctuation in serum amylase, ranging from 115 to 1160% in this study, may occur in patients with macroamylasemia. The reasons for these fluctuations are not clear but may be due to association-dissociation of amylase with serum proteins at variable time intervals. This fluctuation, especially when the amylase becomes normal (as in cases 1 and 3), may lead to confusion in differentiating macroamylasemia from other causes of hyperamylasemia.

UI MeSH Term Description Entries
D007161 Immunoproliferative Small Intestinal Disease A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA. Heavy Chain Disease, IgA Type,IPSID,Lymphoma, Mediterranean,alpha-Chain Disease,Disease, alpha-Chain,Diseases, alpha-Chain,Mediterranean Lymphoma,alpha Chain Disease,alpha-Chain Diseases
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000681 Amylases A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. (Stedman, 25th ed) EC 3.2.1.-. Diastase,Amylase

Related Publications

C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
March 1970, The American journal of gastroenterology,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
January 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
June 2015, Indian pediatrics,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
September 1990, Nederlands tijdschrift voor geneeskunde,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
November 1967, The New England journal of medicine,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
April 2021, Clinical laboratory,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
January 1986, Clinica chimica acta; international journal of clinical chemistry,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
December 1991, Clinical chemistry,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
November 2012, Leukemia & lymphoma,
C K Sachdeva, and S Bank, and R Greenberg, and M Blumstein, and S Weissman
June 1983, Gastroenterologia Japonica,
Copied contents to your clipboard!